Locally-developed drugs approved this year will rake in at least $8B by 2018

Massachusetts biotechs saw the U.S. approval of five drugs in the past year, including treatments for breast cancer, epilepsy and multiple sclerosis...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.